GNAO1
GNAO1 (G protein subunit alpha o1, G-ALPHA-o) is the alpha subunit of the Go heterotrimeric G protein, a transducer that acts downstream of G protein-coupled receptors. It inhibits adenylate cyclases and plays a key role in postsynaptic inhibition of neurotransmitter release. Browse Assay Genie's current range of GNAO1 research reagents below, or read on for the biology behind the target.
Guanine nucleotide-binding proteins (G proteins) function as transducers downstream of G protein-coupled receptors (GPCRs) in numerous signalling cascades, including the regulation of postsynaptic neurotransmitter release. The GNAO1 alpha chain contains the guanine nucleotide binding site and alternates between an active, GTP-bound state and an inactive, GDP-bound state. Signalling by an activated GPCR promotes GDP release and GTP binding. The alpha subunit has low intrinsic GTPase activity that converts bound GTP to GDP, terminating the signal. Both GDP release and GTP hydrolysis are modulated by numerous regulatory proteins.
Signalling is mediated through effector proteins. GNAO1 acts by inhibiting the activity of adenylate cyclases, which leads to decreased intracellular cAMP levels, and it plays a key role in postsynaptic inhibition of neurotransmitter release. The protein is annotated to the cell membrane and belongs to the G-alpha family, G(i/o/t/z) subfamily. The human GNAO1 gene sits in the HGNC group of G protein subunits alpha, group i, and is also listed among microRNA protein coding host genes. Mouse and rat both carry a Gnao1 ortholog.
The NCBI Gene summary describes the encoded protein as the alpha subunit of the Go heterotrimeric G-protein signal-transducing complex. Defects in this gene are a cause of early-onset epileptic encephalopathy, which makes GNAO1 a gene of interest in neurological disease research. Two transcript variants encoding different isoforms have been reported. An earlier HGNC name for the gene was guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O.
GNAO1 relays signals from activated G protein-coupled receptors, cycling between GTP-bound active and GDP-bound inactive states.
By inhibiting adenylate cyclases, GNAO1 lowers intracellular cAMP levels, making it a useful focus for studies of effector control.
GNAO1 plays a key role in postsynaptic inhibition of neurotransmitter release, relevant to neuronal signalling research.
Defects in GNAO1 are a cause of early-onset epileptic encephalopathy, linking the gene to neurological disease studies.
GNAO1 is the alpha subunit of the Go heterotrimeric G protein. It transduces signals from activated GPCRs, inhibits adenylate cyclases to decrease intracellular cAMP, and plays a key role in postsynaptic inhibition of neurotransmitter release. Its low GTPase activity converts bound GTP to GDP and ends the signal.
GNAO1 is also known as G-ALPHA-o, and its full HGNC name is G protein subunit alpha o1. UniProt calls it guanine nucleotide-binding protein G(o) subunit alpha. NCBI Gene reports two transcript variants that encode different isoforms.
Mouse and rat both have a Gnao1 ortholog, so the gene is studied in rodent models; check the datasheet of any product for its validated reactivity. NCBI Gene states that defects in GNAO1 are a cause of early-onset epileptic encephalopathy.
Other G protein subunits, GPCR signalling components and neuronal signalling markers with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P09471; product specifications from Assay Genie datasheets.